Violation Tracker Individual Record
Company:Mylan Specialty, L.P.
Date:November 7, 2013
Offense Group:healthcare-related offenses
Primary Offense:off-label or unapproved promotion of medical products
Secondary Offense:false advertising
Pfizer and Mylan agreed to pay a total of $625,000 in settlement of charges they ran a deceptive advertisement overstating the effectiveness of EpiPen.
Level of Government:state
Action Type:agency action
Agency:Massachusetts Attorney General
Civil or Criminal Case:civil
HQ Country of Parent:Netherlands (reincorporated for tax reasons)
Ownership Structure of Parent:publicly traded
Major Industry of Parent:pharmaceuticals
Specific Industry of Parent:pharmaceuticals
Source Notes:If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.